Absence of V617F-mutated polycythemia vera in obstructive sleep apnea-associated erythrocytosis.
作者信息
Langabeer Stephen E
机构信息
Cancer Molecular Diagnostics, St.James's Hospital, Dublin, Ireland.
出版信息
Sleep Med X. 2022 Oct 15;4:100058. doi: 10.1016/j.sleepx.2022.100058. eCollection 2022 Dec.
Abstract
摘要
相似文献
1
Absence of V617F-mutated polycythemia vera in obstructive sleep apnea-associated erythrocytosis.阻塞性睡眠呼吸暂停相关性红细胞增多症中不存在V617F突变型真性红细胞增多症。
Sleep Med X. 2022 Oct 15;4:100058. doi: 10.1016/j.sleepx.2022.100058. eCollection 2022 Dec.
2
Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis.JAK2 V617F阴性真性红细胞增多症、红细胞增多症和原发性骨髓纤维化中的表型变异与新突变。
Exp Hematol. 2007 Nov;35(11):1641-6. doi: 10.1016/j.exphem.2007.08.010. Epub 2007 Oct 17.
3
Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center.真性红细胞增多症中红细胞生成素水平的诊断性能：综合癌症中心的经验。
Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):224-229. doi: 10.1016/j.clml.2020.11.002. Epub 2020 Nov 5.
4
Polycythemia vera: scientific advances and current practice.真性红细胞增多症：科学进展与当前实践
Semin Hematol. 2005 Oct;42(4):206-20. doi: 10.1053/j.seminhematol.2005.08.003.
5
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera.15例JAK2V617F阴性真性红细胞增多症患者中JAK2外显子12突变的检测
Haematologica. 2009 Mar;94(3):414-8. doi: 10.3324/haematol.13223.
6
Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.真性红细胞增多症、原发性血小板增多症以及原发性骨髓纤维化伴或不伴JAK2 V617F突变时的巨核细胞形态及临床参数
Arch Pathol Lab Med. 2014 Sep;138(9):1203-9. doi: 10.5858/arpa.2013-0018-OA.
7
Polycythaemia Vera JAK 2 Mutation in a Patient with Underlying Chronic Obstructive Pulmonary Disease at a Primary Care Setting.基层医疗环境中一名患有基础慢性阻塞性肺疾病患者的真性红细胞增多症JAK 2突变
Korean J Fam Med. 2020 Jul;41(4):263-266. doi: 10.4082/kjfm.18.0161. Epub 2020 Jun 9.
8
Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea.PRV-1 mRNA表达水平和JAK2V617F突变在真性红细胞增多症与继发性红细胞增多症鉴别诊断及干扰素或羟基脲治疗评估中的应用
Hematology. 2007 Dec;12(6):473-9. doi: 10.1080/10245330701384005.
9
JAK2 V617F mutation is rare in idiopathic erythrocytosis: a difference from polycythemia vera.JAK2 V617F突变在特发性红细胞增多症中罕见：与真性红细胞增多症的差异。
Int J Hematol. 2008 Jul;88(1):82-87. doi: 10.1007/s12185-008-0103-6. Epub 2008 Jun 6.
10
Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia.真性红细胞增多症、原发性骨髓纤维化和原发性血小板增多症中的细胞遗传学、JAK2和MPL突变
Rev Bras Hematol Hemoter. 2011;33(6):417-24. doi: 10.5581/1516-8484.20110116.
本文引用的文献
1
JAK2 Unmutated Polycythaemia-Real-World Data of 10 Years from a Tertiary Reference Hospital.JAK2未突变型真性红细胞增多症——来自一家三级转诊医院的10年真实世界数据。
J Clin Med. 2022 Jun 13;11(12):3393. doi: 10.3390/jcm11123393.
2
Genetic Background of Polycythemia Vera.真性红细胞增多症的遗传背景。
Genes (Basel). 2022 Apr 2;13(4):637. doi: 10.3390/genes13040637.
3
Investigation and management of erythrocytosis.红细胞增多症的调查与处理
CMAJ. 2020 Aug 10;192(32):E913-E918. doi: 10.1503/cmaj.191587.
4
Obstructive Sleep Apnea in Adults.成人阻塞性睡眠呼吸暂停
N Engl J Med. 2019 Apr 11;380(15):1442-1449. doi: 10.1056/NEJMcp1816152.
5
Simultaneous occurrence of multiple aetiologies of polycythaemia: renal cell carcinoma, sleep apnoea syndrome, and relative polycythaemia in a smoker with masked polycythaemia rubra vera.真性红细胞增多症多种病因同时出现：肾细胞癌、睡眠呼吸暂停综合征，以及一名隐匿性真性红细胞增多症吸烟者的相对性红细胞增多症。
J Clin Pathol. 2000 Jul;53(7):561-4. doi: 10.1136/jcp.53.7.561.
Zotero 插件